Literature DB >> 17149796

Tandem mass spectrometry of kahalalides: identification of two new cyclic depsipeptides, kahalalide R and S from Elysia grandifolia.

Supriya Tilvi1, C G Naik.   

Abstract

Spectra obtained using electrospray ionization mass spectrometry (ESI-MS) of the mollusk Elysia grandifolia showed a cluster of molecular ion peaks centered at a molecular mass of 1478 Da (kahalalide F, an anticancer agent). Two new molecules, kahalalide R (m/z 1464) and S (m/z 1492) were characterized using tandem mass spectrometry. The mass differences of 14 Da suggest that they are homologous molecules. In addition, previously identified kahalalide D and kahalalide G are also reported. However, the ESI-MS of the mollusk's algal diet Bryopsis plumosa showed the presence of only kahalalide F. The amino acid sequences of kahalalide R and S are proposed using collision-induced dissociation (CID) experiments of singly and doubly charged molecular ions and by comparison with the amino acid sequence of kahalalide F. The pathway is presented for the loss of amino acid residues in kahalalide F. It is observed that there is sequential loss of amino acids in the linear peptide chain, but in the cyclic part the ring opens at the amide bond rather than at the lactone linkage, and the loss of amino acid residues is not sequential. The CID experiment of the alkali-metal-cationized molecular ions shows that the sodium and potassium ions coordinate to the amide nitrogen/oxygen in the linear peptide chain of the molecule and not to the lactone oxygen of the lactone. In the case of kahalalide D, CID of the protonated peptide opens the depsipeptide ring to form a linear peptide with acylium ion, and fragment ion signals indicate losses of amino acids in sequential order. In this study, tandem mass spectrometry has provided the detailed information required to fully characterize the new peptides. Copyright 2006 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17149796     DOI: 10.1002/jms.1140

Source DB:  PubMed          Journal:  J Mass Spectrom        ISSN: 1076-5174            Impact factor:   1.982


  14 in total

1.  In vitro and in vivo evaluation of select kahalalide F analogs with antitumor and antifungal activities.

Authors:  Abbas Gholipour Shilabin; Mark T Hamann
Journal:  Bioorg Med Chem       Date:  2011-06-25       Impact factor: 3.641

2.  Multifarious allelochemicals exhibiting antifungal activity from Bacillus subtilis MBCU5.

Authors:  Urja Pandya; Sunita Prakash; Kishor Shende; Umesh Dhuldhaj; Meenu Saraf
Journal:  3 Biotech       Date:  2017-06-29       Impact factor: 2.406

Review 3.  Chemistry and biology of kahalalides.

Authors:  Jiangtao Gao; Mark T Hamann
Journal:  Chem Rev       Date:  2011-04-11       Impact factor: 60.622

Review 4.  High-value compounds from the molluscs of marine and estuarine ecosystems as prospective functional food ingredients: An overview.

Authors:  Kajal Chakraborty; Minju Joy
Journal:  Food Res Int       Date:  2020-08-31       Impact factor: 6.475

5.  Pagoamide A, a Cyclic Depsipeptide Isolated from a Cultured Marine Chlorophyte, Derbesia sp., Using MS/MS-Based Molecular Networking.

Authors:  Yueying Li; Hao-Bing Yu; Yi Zhang; Tiago Leao; Evgenia Glukhov; Marsha L Pierce; Chen Zhang; Hyunwoo Kim; Huanru Henry Mao; Fang Fang; Garrison W Cottrell; Thomas F Murray; Lena Gerwick; Huashi Guan; William H Gerwick
Journal:  J Nat Prod       Date:  2020-01-09       Impact factor: 4.050

6.  Kahalalides V-Y isolated from a Hawaiian collection of the sacoglossan mollusk Elysia rufescens.

Authors:  Karumanchi V Rao; Min Kyun Na; Jennifer C Cook; Jiangnan Peng; Rae Matsumoto; Mark T Hamann
Journal:  J Nat Prod       Date:  2008-04-12       Impact factor: 4.050

7.  Computationally assisted assignment of kahalalide Y configuration using an NMR-constrained conformational search.

Authors:  Mohamed A Albadry; Khaled M Elokely; Bin Wang; John J Bowling; Mohamed F Abdelwahab; Mohamed H Hossein; Robert J Doerksen; Mark T Hamann
Journal:  J Nat Prod       Date:  2013-01-30       Impact factor: 4.050

8.  Lysosome and HER3 (ErbB3) selective anticancer agent kahalalide F: semisynthetic modifications and antifungal lead-exploration studies.

Authors:  Abbas Gholipour Shilabin; Noer Kasanah; David E Wedge; Mark T Hamann
Journal:  J Med Chem       Date:  2007-08-14       Impact factor: 7.446

9.  5-OHKF and NorKA, depsipeptides from a Hawaiian collection of Bryopsis pennata: binding properties for NorKA to the human neuropeptide Y Y1 receptor.

Authors:  Jiangtao Gao; Catherina Caballero-George; Bin Wang; Karumanchi V Rao; Abbas Gholipour Shilabin; Mark T Hamann
Journal:  J Nat Prod       Date:  2009-12       Impact factor: 4.050

10.  Interpretation of tandem mass spectra obtained from cyclic nonribosomal peptides.

Authors:  Wei-Ting Liu; Julio Ng; Dario Meluzzi; Nuno Bandeira; Marcelino Gutierrez; Thomas L Simmons; Andrew W Schultz; Roger G Linington; Bradley S Moore; William H Gerwick; Pavel A Pevzner; Pieter C Dorrestein
Journal:  Anal Chem       Date:  2009-06-01       Impact factor: 6.986

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.